- Concomitant Exposure to Non-CDI Antibiotics Increases CDI Recurrence Risk
- Molnupiravir Not Superior to Placebo for Intra-Household PEP Against COVID-19
- US Resumes Free COVID-19 Test Program
- ChatGPT Generates Differential Diagnoses With Similar Accuracy to Emergency Doctors
- Do Infections or Autoimmune Diseases Better Predict Dementia Risk?
- Inclusion of Macrolides in Treatment for CAP Reduces 30-Day Mortality
- Real-World Risk Factors for Severe COVID-19 in Systemic Lupus Erythematosus
- COVID-19 Pandemic Impact on Gout Diagnosis and Therapy Initiation
- Just 23% of US Adults ‘Definitely’ Plan to Get New COVID-19 Vaccine
- Study Examines Prevalence of Long COVID in Adults and Pediatric Patients
- More Progress Identified in Women vs Minority Leadership Diversity in Medicine
- Increase in Types 1 and 2 Diabetes Identified in US Youth During Pandemic
Clinical Tools
Powered by
Powered by 
Can a Breath Test Detect Mesothelioma? It’s Too Soon to Tell.
COVID-19 Vaccines Increase PD-L1 Levels, Might Reverse Treatment Resistance in NSCLC
Predictors of VTE Risk Identified in Patients With Thrombophilia and Cancer
Long COVID May Affect Millions of Americans Never Diagnosed
Azelaic Acid Effectively Treats Rosacea, Acne Vulgaris, and Melasma
